Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the LawFetal Development

Testimony of CLI Assoc. Scholar in Support of the Prenatal Nondiscrimination Act

On April 14, the House Judiciary Committee held a hearing on HR 4924, the Prenatal Nondiscrimination Act (PRENDA) of 2016, sponsored by Rep. Trent Franks. The bill would prohibit discrimination against the unborn based on the preference of sex or race alone. Charlotte Lozier Institute associate scholar Anna Higgins, J.D. testified in support of the bill, and summarized her newly published paper on sex-selection abortion.

 

(CLI Assoc. Scholar Anna Higgins, J.D. testifying, April 14, 2016)
(CLI Assoc. Scholar Anna Higgins, J.D. testifying, April 14, 2016)

 

Some excerpts from her testimony are here (footnotes available in full text):

 

Sex selective abortion is defined as choosing to abort a preborn child based solely on the child’s sex. Any discrimination against a unique human individual based on sex alone constitutes sex discrimination. Congress has the opportunity, through the passage of H.R. 4924 to prohibit the discriminatory practice of sex-selective abortion, thereby confirming the fact that women have the same inherent human and civil rights as men.

…

The practice of sex-selective abortion implies a right to choose not just whether or not to have a child, but the right to choose the characteristics of a child. The ethical implications of such a practice are numerous and unacceptable. The result of continuing to allow this practice is an implicit approval of the practice of assigning value to a person based on his or her sex alone.

 

To continue reading the full testimony, please see: Written Testimony of Anna Higgins, J.D. in support of PRENDA

 

Video of the full hearing can be watched on the House Judiciary Committee’s website here.

(Prolife witnesses after the hearing [L-R]: CLI Assoc. Scholar Anna Higgins, Catherine Davis [National Black Prolife Coalition; The Restoration Project], Rep. Trent Franks [R-AZ-8], and Rev. Derek McCoy [Center for Urban Renewal and Education])
(Prolife witnesses after the hearing [L-R]: CLI Assoc. Scholar Anna Higgins, Catherine Davis [National Black Prolife Coalition; The Restoration Project], Rep. Trent Franks [R-AZ-8], and Rev. Derek McCoy [Center for Urban Renewal and Education])

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification.

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined.

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

A person in a white shirt dropping an abortion ballot into a white box against a yellow background.

Abortion on the Ballot in November

October 2, 2026

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image